Solid Biosciences Inc. (SLDB)

6.84 USD-2.29%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$763.4M52 Week Range: 4.34 – 11.15
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -1.76
The live quote provider is unreachable; the last known close is shown.

Solid Biosciences Inc. (SLDB) is not among the 30 most-held stocks of the tracked superinvestor set. Price 6.84 USD; market cap $763.4M.

Price & valuation

Prev Close7
Open—
Day Range—
52 Week Range4.34 – 11.15
Volume—
Avg Volume (3M)—
Market Cap$763.4MSEC 10-Q, 10/30/2026
BetaVolatility vs the market. Above 1: swings harder than the index.1.732 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-1.76SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own SLDB?

Solid Biosciences Inc. (SLDB) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on SLDB bullish or bearish?

SLDB is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.